Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
5.19
-0.96 (-15.61%)
At close: May 12, 2025, 4:00 PM
5.35
+0.16 (3.08%)
After-hours: May 12, 2025, 7:50 PM EDT
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $651.30M in the quarter ending March 31, 2025, a decrease of -1.63%. This brings the company's revenue in the last twelve months to $2.69B, down -12.73% year-over-year. In the year 2024, Fortrea Holdings had annual revenue of $2.70B, down -5.14%.
Revenue (ttm)
$2.69B
Revenue Growth
-12.73%
P/S Ratio
0.17
Revenue / Employee
$166,600
Employees
16,120
Market Cap
469.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
Dec 31, 2020 | 2.58B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
FTRE News
- 15 hours ago - Fortrea Holdings Inc. (FTRE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 hours ago - Fortrea Reports First Quarter 2025 Results - GlobeNewsWire
- 21 hours ago - Fortrea Announces CEO Stepping Down - GlobeNewsWire
- 11 days ago - Fortrea Named a Leader in Everest Group's Pharmacovigilance Operations PEAK Matrix® Assessment 2025 - GlobeNewsWire
- 6 weeks ago - Bragar Eagel & Squire, P.C. Is Investigating Fortrea and Ibotta and Encourages Investors to Contact the Firm - GlobeNewsWire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Fortrea Holdings Inc. (FTRE) Shareholders to Inquire about Securities Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Connect - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings Inc. (FTRE) And Encourages Shareholders to Reach Out - Accesswire